Southmead Hospital is a large public National Health Service hospital, situated in the area of Southmead, though in Horfield ward, in the northern suburbs of Bristol, England. It is part of the North Bristol NHS Trust.

There are 996 beds in Southmead Hospital.

During the past decade, Southmead Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 20 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 15 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southmead Hospital" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "University of Oxford" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Institute of Cancer Research, United Kingdom" with 3 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southmead Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Queen Mary University of London" with 3 trials as a collaborator, "University of Bristol" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Medical Research Council" with 2 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "Southmead Hospital" are "Idiopathic Pulmonary Fibrosis" (10 trials), "Prostate Cancer" (7 trials), "Multiple Myeloma" (5 trials), "Chronic Kidney Disease" (3 trials) and "Chronic Pain" (3 trials). Many other conditions were trialed in "Southmead Hospital" in a lesser frequency.

Most popular intervention types in "Southmead Hospital" are "Drug" (50 trials), "Device" (21 trials), "Other" (12 trials), "Procedure" (9 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Atrasentan" (2 trials), "Bosentan" (2 trials), "Deep Brain Stimulation (DBS)" (2 trials) and "Nintedanib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southmead Hospital" are 79 trials for "All" genders, 9 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Southmead Hospital". undefined are not yet recruiting, 13 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Southmead Hospital, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Southmead Hospital, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 20 trials that are defined as “Not Applicable".